Related Articles
Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells
Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway Corrigendum in /10.3892/ol.2017.6464
Dihydroartemisinin inhibits vascular endothelial growth factor‑induced endothelial cell migration by a p38 mitogen‑activated protein kinase‑independent pathway
Dihydroartemisinin inhibits endothelial cell migration via the TGF‑β1/ALK5/SMAD2 signaling pathway
Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling